1. Home
  2. PSTV vs EDUC Comparison

PSTV vs EDUC Comparison

Compare PSTV & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • EDUC
  • Stock Information
  • Founded
  • PSTV 1996
  • EDUC 1965
  • Country
  • PSTV United States
  • EDUC United States
  • Employees
  • PSTV N/A
  • EDUC N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • EDUC Consumer Specialties
  • Sector
  • PSTV Health Care
  • EDUC Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • EDUC Nasdaq
  • Market Cap
  • PSTV 10.4M
  • EDUC 11.4M
  • IPO Year
  • PSTV N/A
  • EDUC N/A
  • Fundamental
  • Price
  • PSTV $0.18
  • EDUC $1.32
  • Analyst Decision
  • PSTV Strong Buy
  • EDUC
  • Analyst Count
  • PSTV 3
  • EDUC 0
  • Target Price
  • PSTV $13.00
  • EDUC N/A
  • AVG Volume (30 Days)
  • PSTV 13.6M
  • EDUC 6.3K
  • Earning Date
  • PSTV 08-13-2025
  • EDUC 07-10-2025
  • Dividend Yield
  • PSTV N/A
  • EDUC N/A
  • EPS Growth
  • PSTV N/A
  • EDUC N/A
  • EPS
  • PSTV N/A
  • EDUC N/A
  • Revenue
  • PSTV $5,206,000.00
  • EDUC $34,191,000.00
  • Revenue This Year
  • PSTV $13.26
  • EDUC N/A
  • Revenue Next Year
  • PSTV $8.84
  • EDUC N/A
  • P/E Ratio
  • PSTV N/A
  • EDUC N/A
  • Revenue Growth
  • PSTV N/A
  • EDUC N/A
  • 52 Week Low
  • PSTV $0.16
  • EDUC $0.92
  • 52 Week High
  • PSTV $2.31
  • EDUC $2.49
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 29.61
  • EDUC 47.96
  • Support Level
  • PSTV $0.16
  • EDUC $1.32
  • Resistance Level
  • PSTV $0.36
  • EDUC $1.46
  • Average True Range (ATR)
  • PSTV 0.04
  • EDUC 0.09
  • MACD
  • PSTV -0.00
  • EDUC -0.01
  • Stochastic Oscillator
  • PSTV 8.38
  • EDUC 5.88

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About EDUC Educational Development Corporation

Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.

Share on Social Networks: